• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素拮抗剂周期中,口服避孕药预处理显著降低持续性妊娠的可能性:一项更新的荟萃分析。

Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis.

机构信息

Department of Obstetrics and Gynecology, University Clinic of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.

出版信息

Fertil Steril. 2010 Nov;94(6):2382-4. doi: 10.1016/j.fertnstert.2010.04.025. Epub 2010 May 26.

DOI:10.1016/j.fertnstert.2010.04.025
PMID:20537631
Abstract

Ongoing pregnancy rate (PR) per randomized woman was found to be significantly lower in patients with oral contraceptive (OC) pill pretreatment (relative risk: 0.80, 95% confidence interval [CI]: 0.66-0.97; rate difference: -5%, 95% CI: -10% to -1%; fixed effects model) after pooling data from six randomized controlled trials encompassing 1,343 patients. Duration of stimulation (weighted mean difference [WMD]: +1.33 days, 95% CI: +0.61-2.05) and gonadotropin consumption (WMD: +360 IUs, 95% CI: +158-563) were significantly increased after OC pretreatment, but there was no statistically significant gain in the number of cumulus-oocyte complexes (WMD: +0.6 cumulus-oocyte complexes, 95% CI: -0.08-1.25).

摘要

在汇总了涵盖 1343 名患者的六项随机对照试验的数据后,我们发现,与未进行口服避孕药(OC)预处理的患者相比,OC 预处理患者的随机化女性的持续妊娠率(PR)显著降低(相对风险:0.80,95%置信区间 [CI]:0.66-0.97;率差:-5%,95%CI:-10%至-1%;固定效应模型)。预处理 OC 后,刺激持续时间(加权均数差 [WMD]:+1.33 天,95%CI:+0.61-2.05)和促性腺激素消耗(WMD:+360IU,95%CI:+158-563)显著增加,但卵丘-卵母细胞复合物的数量并没有显著增加(WMD:+0.6 个卵丘-卵母细胞复合物,95%CI:-0.08-1.25)。

相似文献

1
Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis.促性腺激素释放激素拮抗剂周期中,口服避孕药预处理显著降低持续性妊娠的可能性:一项更新的荟萃分析。
Fertil Steril. 2010 Nov;94(6):2382-4. doi: 10.1016/j.fertnstert.2010.04.025. Epub 2010 May 26.
2
Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis.
Fertil Steril. 2008 Oct;90(4):1055-63. doi: 10.1016/j.fertnstert.2007.07.1354. Epub 2007 Dec 3.
3
Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial.口服避孕药预处理对接受促性腺激素释放激素拮抗剂和重组促卵泡生成素刺激进行体外受精的患者持续妊娠率的影响。一项随机对照试验。
Hum Reprod. 2006 Feb;21(2):352-7. doi: 10.1093/humrep/dei348. Epub 2005 Nov 3.
4
Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide.对年轻低反应患者的刺激:黄体期雌激素/促性腺激素释放激素拮抗剂预激方案与口服避孕药小剂量促性腺激素释放激素的比较。
Fertil Steril. 2011 Feb;95(2):592-5. doi: 10.1016/j.fertnstert.2010.10.003. Epub 2010 Nov 12.
5
Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.在促性腺激素释放激素(GnRH)拮抗剂周期中,取卵前给予GnRH激动剂能否提高妊娠率?一项前瞻性随机研究。
Fertil Steril. 2008 Oct;90(4):1087-93. doi: 10.1016/j.fertnstert.2007.07.1316. Epub 2007 Nov 26.
6
Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.促性腺激素释放激素激动剂联合低剂量人绒毛膜促性腺激素用于体外受精新鲜自体周期的最终卵母细胞成熟。
Fertil Steril. 2008 Jul;90(1):231-3. doi: 10.1016/j.fertnstert.2007.06.030. Epub 2007 Nov 5.
7
Progesterone administration route in gonadotropin-releasing hormone antagonist cycles.促性腺激素释放激素拮抗剂周期中的孕酮给药途径
Fertil Steril. 2010 Aug;94(3):e47; author reply e48. doi: 10.1016/j.fertnstert.2010.04.014.
8
Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.在接受体外受精/卵胞浆内单精子注射的低反应者中,GnRH拮抗剂方案(有无口服避孕药预处理)与GnRH激动剂低剂量长方案的比较。
Fertil Steril. 2009 Nov;92(5):1758-60. doi: 10.1016/j.fertnstert.2009.05.013. Epub 2009 Jun 12.
9
Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment.根据口服避孕药预处理情况,采用促性腺激素释放激素拮抗剂方案刺激的女性早期妊娠丢失情况。
Fertil Steril. 2007 May;87(5):1098-101. doi: 10.1016/j.fertnstert.2006.08.098. Epub 2007 Jan 16.
10
Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?医生的经验会影响接受GnRH拮抗剂控制性卵巢刺激的患者的体外受精成功率吗?
Fertil Steril. 2008 Mar;89(3):736-7. doi: 10.1016/j.fertnstert.2007.03.049. Epub 2007 May 11.

引用本文的文献

1
Management of LH/FSH deficiency among assisted reproduction specialists in Spain: a Delphi consensus.西班牙辅助生殖专家对促黄体生成素/促卵泡生成素缺乏症的管理:德尔菲共识
Front Endocrinol (Lausanne). 2025 Aug 5;16:1498062. doi: 10.3389/fendo.2025.1498062. eCollection 2025.
2
Influence of combined oral contraceptive pill before PPOS protocol on egg donors and recipients' outcomes: an international multicenter retrospective study.在PPOS方案前使用复方口服避孕药对卵子捐赠者和接受者结局的影响:一项国际多中心回顾性研究
J Assist Reprod Genet. 2025 May 29. doi: 10.1007/s10815-025-03519-0.
3
Pretreatment with oral contraceptives benefit POSEIDON group 1 low prognosis patients during GnRH-antagonist protocol: a propensity score-matched retrospective cohort study.
口服避孕药预处理对 GnRH 拮抗剂方案中 POSEIDON 组 1 低预后患者有益:一项倾向评分匹配的回顾性队列研究。
J Ovarian Res. 2025 Mar 7;18(1):47. doi: 10.1186/s13048-025-01613-6.
4
Impact of GnRH antagonist pretreatment on oocyte yield after ovarian stimulation: A retrospective analysis.促性腺激素释放激素拮抗剂预处理对卵巢刺激后卵母细胞产量的影响:一项回顾性分析。
PLoS One. 2024 Oct 7;19(10):e0308666. doi: 10.1371/journal.pone.0308666. eCollection 2024.
5
Previous Use of Combined Oral Contraception in High Complexity Assisted Reproduction Treatments in Protocol with Oral Progestin - Previous use of COC and ART.在口服孕激素方案的高复杂性辅助生殖治疗中联合口服避孕药的既往使用情况——联合口服避孕药和辅助生殖技术的既往使用情况。
JBRA Assist Reprod. 2024 Dec 3;28(4):639-649. doi: 10.5935/1518-0557.20240058.
6
What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis.ART 治疗中卵巢刺激时最佳 GnRH 拮抗剂方案是什么?系统评价和网络荟萃分析。
Hum Reprod Update. 2023 May 2;29(3):307-326. doi: 10.1093/humupd/dmac040.
7
Another option for cycle programming: follicular start estradiol in oocyte donation cycles.周期规划的另一种选择:卵母细胞捐赠周期中的卵泡期起始雌二醇。
F S Rep. 2022 Jan 22;3(1):10. doi: 10.1016/j.xfre.2022.01.003. eCollection 2022 Mar.
8
Follicular phase cycle programming using estradiol in oocyte donors-a convenient and effective approach.使用雌二醇对卵母细胞捐献者进行卵泡期周期编程——一种便捷有效的方法。
F S Rep. 2022 Jan 5;3(1):20-25. doi: 10.1016/j.xfre.2021.12.007. eCollection 2022 Mar.
9
Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT.用于体外受精周期的促性腺激素释放激素拮抗剂治疗前使用口服避孕药或戊酸雌二醇与不进行预处理的比较:一项随机对照试验。
Int J Reprod Biomed. 2018 Aug;16(8):535-540.
10
Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.印度多囊卵巢综合征女性口服避孕药使用的共识声明。
J Hum Reprod Sci. 2018 Apr-Jun;11(2):96-118. doi: 10.4103/jhrs.JHRS_72_18.